Study of KHN702 tablets in healthy volunteers
This study tests a new medicine called KHN702 in healthy volunteers to see how the body processes it and whether it is safe. It is an early-stage trial, so participants will help find out how the drug works before it is studied in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You must be generally healthy, with no major medical conditions (like heart, liver, or kidney disease) or significant abnormalities found in routine checkups.
- You need to stop taking all medications and supplements (even over-the-counter ones) for at least 2 weeks before the study and during the trial.
- You must be willing to follow strict rules about diet, smoking, and alcohol during the study.
- If you are a woman who can become pregnant, you must use effective birth control and not donate eggs; if you are a man, you must not donate sperm for 3 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.
This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.
This trial is testing a new medicine called KHN707 in healthy people. The goal is to see if it is safe and how the body handles it. It is an early-stage study, so it is not intended to treat any condition yet.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.